Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating immune complexes in human osteosarcoma.

K Y Tsang, I Singh, W S Blakemore

    Journal of the National Cancer Institute
    |April 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice.

    Journal of thrombosis and haemostasis : JTH·2004
    Same author

    Tuberculosis of zygoma.

    International journal of pediatric otorhinolaryngology·2003
    Same author

    Idiopathic cases of male infertility from a region in India show low incidence of Y-chromosome microdeletion.

    Journal of biosciences·2003
    Same author

    Volume and colour coding for syringes.

    Anaesthesia·2003
    Same author

    Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.

    Circulation·2003
    Same author

    Identification of a mouse orthologue of the CED-6 gene of Caenorhabditis elegans.

    Plasmid·2003

    Elevated levels of circulating immune complexes were found in most osteosarcoma patients, correlating with increased serum blocking activity against tumor cells. This suggests immune complexes may play a role in osteosarcoma progression.

    Area of Science:

    • Immunology
    • Oncology

    Background:

    • Circulating immune complexes (CICs) are implicated in various autoimmune diseases and cancers.
    • Understanding the role of CICs in osteosarcoma is crucial for developing targeted therapies.

    Purpose of the Study:

    • To investigate the presence and levels of CICs in osteosarcoma patients.
    • To assess the correlation between CICs and serum-mediated blocking activity against osteosarcoma cells.

    Main Methods:

    • Radioimmunoassays (C1q and Raji cell) were used to detect and quantify CICs in patient and normal sera.
    • Lymphocyte cytotoxicity assays were performed to evaluate serum blocking activity against osteosarcoma cell lines.
    • Serum fractionation was employed to analyze specific components like gamma-globulins.

    Related Experiment Videos

    Main Results:

    • Six out of eight osteosarcoma patients exhibited elevated CIC levels compared to normal individuals.
    • A positive correlation was observed between high CIC levels and increased serum blocking activity.
    • No free tumor-specific antibodies were detected in the gamma-globulin fractions of patients with high CICs and blocking activity.

    Conclusions:

    • Osteosarcoma patients frequently present with elevated circulating immune complexes.
    • These immune complexes are associated with enhanced serum-mediated suppression of anti-tumor lymphocyte activity.
    • The findings suggest a potential role for immune complexes in immune evasion in osteosarcoma.